Updated: July 12, 2026
Funding raised
$1800M
About the program
Program type
Investment stage
Description
Novo Holdings (Life Sciences Fund) is a venture capital firm based in Denmark, focusing on Series A stage investments. The fund actively supports founders building innovative solutions in Deep Tech, SaaS, providing strategic guidance and capital to help startups scale.